GW Pharmaceuticals Plc (NASDAQ:GWPH) Appoints Two Top Officials

GW Pharmaceuticals Plc (NASDAQ:GWPH) has announced its bringing on board Scott Giacobello to serve in the capacity of the Chief Financial Officer. The company through its cannabinoid product platform has over the years engaged in the discovery, development as well as commercialization of novel products and still hopes to do much more in years to come towards promoting good health around the globe.

The company’s headquarters in the U.S are located in Carlsbad, California and this is where the new top official will be based. He will be reporting to the leading company’s Chief Executive Officer Justin Gover and during this appointment all eyes are focused on him to see what value and contribution he brings to the company.

Some time back, there was a growing need for the company to set up a new executive role. In line with Scott Giacobello’s appointment was the appointment Adam George, to serve in the capacity of Managing Director UK. The newly established role had a wide array of responsibilities linked to UK operations. This official was and still continues to be answerable to GW’s Chief Executive Officer Justin Gover.

Justin Gover lately made some remarks stating that the company is headed towards a promising future even by the look of the appointments it has been making lately. He termed them important leadership appointments which happen to be an on-point reflection of what the company has grown to become in the direction of evolving to become a significant transatlantic commercial-stage biopharmaceutical provider.

At the moment, the company awaits the Epidiolex approval and launch as well and according to the top executive; it is a good thing that the company is listed on NASDAQ. As an organization, they are prepared to make the transition from being a Foreign Private Issuer reporting under IFRS to moving a notch-higher to be the domestic registrant reporting and this will be under the umbrella of the US GAAP.

Giacobello boasts of a wealth of experience after working in a number of top positions. However, the latest have been his serving at Black and Decker Corporation not of course forgetting Ernst and Young. He happens to be a Certified Public Accountant and a proud holder of a bachelor’s degree in business administration which he obtained from University of Notre Dame.

While we are still talking about MMJ companies, a micro cap company that needs mention is American Premium Water (HIPH). As per today’s press release, the company is looking forward to launch its CBD-water. “We are excited to be increasing our reach in the most sought out industry in America. CBD is a non-psychoactive byproduct of the hemp plant, widely believed to have numerous health benefits. As a Naturalist, I feel that our customers deserve to live a healthy lifestyle,” said Founder Alfred T. Culbreth. Click HERE to read more on HIPH.

By Jaime Williams

Jaime is a MBA graduate from UC San Diego and has written for for over 3 months now. She has a particular fondness for the medical marijuana industry but also likes writing on energy, consumer goods, and technology.

Leave a Reply

Your email address will not be published. Required fields are marked *

News of Epidiolex And On Posting Impressive Results, GW Pharmaceuticals Plc (OTCMKTS:GWPRF) Records Weekly Gains of 10% in Stock Price Marapharm Ventures Inc (OTCMKTS:MRPHF) Signs A LOI To Acquire Full Spectrum Medicinal Inc GW Pharmaceuticals plc (NASDAQ:GWPH) Presents New Epidiolex Data

Pin It on Pinterest